GENERATION BIO CO (GBIO)
US37148K1007 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to GBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.4. This target is 164.11% above the current price.
GBIO was analyzed by 13 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about GBIO.
In the previous month the buy percentage consensus was at a similar level.
GBIO was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-10 | Needham | Reiterate | Buy -> Buy |
| 2024-03-07 | Needham | Maintains | Buy -> Buy |
| 2024-03-07 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-10 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-10-23 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2023-10-19 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-08-16 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-08-03 | Needham | Reiterate | Buy |
| 2023-08-03 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-05-11 | Needham | Reiterate | Buy -> Buy |
| 2023-04-19 | Needham | Reiterate | Buy |
| 2023-03-24 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-23 | Needham | Reiterate | Buy |
| 2023-03-06 | JMP Securities | Maintains | Market Outperform |
| 2023-02-24 | Needham | Maintains | Buy |
| 2023-01-19 | JMP Securities | Maintains | Market Outperform |
| 2022-11-08 | Canaccord Genuity | Initiate | Buy |
| 2022-08-08 | JMP Securities | Maintains | Market Outperform |
| 2022-08-05 | Needham | Maintains | Buy |
| 2021-12-15 | JMP Securities | Maintains | Market Outperform |
| 2021-12-15 | Needham | Maintains | Buy |
| 2021-06-08 | JMP Securities | Initiate | Market Outperform |
| 2021-02-24 | William Blair | Initiate | Outperform |
| 2021-02-18 | Needham | Initiate | Buy |